Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Anti-inflammatory SSTR2 ligands

Tools
- Tools
+ Tools

Royall, Sophie C. (2012) Anti-inflammatory SSTR2 ligands. PhD thesis, University of Warwick.

[img]
Preview
Text
WRAP_THESIS_Royall_2012.pdf - Submitted Version

Download (7Mb) | Preview
[img] Other (Email permission for digitisation)
RE Document into WRAP for REF.msg - Other
Embargoed item. Restricted access to Repository staff only

Download (69Kb)
Official URL: http://webcat.warwick.ac.uk/record=b2585529~S1

Request Changes to record.

Abstract

Broad-Spectrum Chemokine Inhibitors (BSCIs) are a novel type of anti-inflammatory drug, discovered by Fox and colleagues, which act through the receptor SSTR2. Chapter 1 consists of the story of the development of current BSCIs and a literature review of existing SSTR2 ligands.
In Chapter 2 a series of receptor probes were synthesised based on existing SSTR2 ligands, BSCIs and a hybrid of the two. Biological data were gained determining their SSTR2 binding ability and their extent of leukocyte migration inhibition.
In Chapter 3 a series of small molecules were synthesised based on the structure of highly potent BSCIs. Once again biological data were gained determining their SSTR2 binding ability and their extent of leukocyte migration inhibition.
In Chapter 4 a series of BSCIs were synthesised which contained substituted aromatic groups using an iron-cross coupling reaction. Biological data were gained to determine these compounds SSTR2 binding ability. Further iron cross-coupling reactions were carried out to determine the scope of these reactions and their applications in medicinal synthetic chemistry.
This works has gained evidence to support a split binding site theory for SSTR2. Somatostatin and BSCIs bind in slightly different area of the binding site, and through functional selectivity somatostatin structural analogues can exert an anti-inflammatory effect while somatostatin does not.

Item Type: Thesis or Dissertation (PhD)
Subjects: Q Science > QD Chemistry
R Medicine > RM Therapeutics. Pharmacology
Library of Congress Subject Headings (LCSH): Chemokines, Anti-inflammatory agents, Ligand binding (Biochemistry)
Official Date: February 2012
Dates:
DateEvent
February 2012Submitted
Institution: University of Warwick
Theses Department: Department of Chemistry
Thesis Type: PhD
Publication Status: Unpublished
Supervisor(s)/Advisor: Fox, David
Sponsors: Engineering and Physical Sciences Research Council (EPSRC) ; University of Warwick. Molecular Organisation and Assembly in Cells ; Funxional Therapeutics Ltd.
Extent: xx, 307 leaves : illustrations, charts
Language: eng

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: publications@live.warwick.ac.uk
Contact Details
About Us